
AMN Healthcare Services (AMN) just reported second quarter 2026 results that moved from a loss to a profit, along with higher sales figures. The company also issued fresh revenue guidance for the third quarter.
See our latest analysis for AMN Healthcare Services.
Despite the earnings rebound, AMN Healthcare Services shares have been under pressure in the short term, with a 1-day share price return of down 6.1% and a 7-day share price return of down 11.26%. The year to date share price return of 103.7% and 1-year total shareholder return of 82.03% still point to earlier strong momentum that contrasts with weaker total shareholder returns over 3 and 5 years.
If this earnings move has you reassessing healthcare exposure, it can help to widen the opportunity set and review 42 healthcare AI stocks.
After such a sharp rebound in AMN Healthcare Services earnings and a strong 1-year share price run, it is fair to ask whether most of the upside has already played out or if the recent pullback is opening up fresh value.
Against AMN Healthcare Services' last close of $30.80, the most followed narrative fair value of $31.86 implies only a small discount, which keeps attention on the assumptions behind that number.
Diversification beyond core travel nursing into areas like allied health, international nurse staffing, education, language services, and labor disruption support is helping to stabilize earnings, reduce business risk, and open additional channels for double-digit revenue and EBITDA growth, especially as visa-related headwinds ease.
Want to see what is really backing that modest upside for AMN Healthcare Services? The narrative leans on specific revenue paths, margin recovery and a future earnings multiple that has been carefully calibrated against sector norms. Curious how all of those moving parts add up to a fair value just above today’s price?
Result: Fair Value of $31.86 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, AMN Healthcare Services still faces risks if hospitals continue shifting toward permanent staff and internal float pools, or if pricing pressure further compresses margins.
Find out about the key risks to this AMN Healthcare Services narrative.
There is a different read on AMN Healthcare Services when looking at its P/S ratio of 0.3x. That level sits well below the US Healthcare industry average of 1.4x and the peer average of 1.8x, yet it is in line with the fair ratio of 0.3x that the market could move toward.
This mix of apparent discount to industry and peers, but alignment with the fair ratio, leaves you weighing whether the gap reflects a margin of safety or a signal that the business still needs to earn back a richer sales multiple over time.
See what the numbers say about this price — find out in our valuation breakdown.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMN Healthcare Services for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 51 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With mixed signals across AMN Healthcare Services earnings, valuation and recent share price moves, it helps to look past the headlines and check the details yourself. If you want a quick snapshot of what the market is optimistic about, start with the 1 key reward.
If you are reassessing your portfolio after AMN Healthcare Services earnings, now is the moment to scan for fresh ideas before the next big moves leave you behind.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com